Yonglin Pu
0000-0002-9583-8185
2 papers found
Refreshing results…
Primary resistance to CD19-directed chimeric antigen receptor T-cell therapy in T-cell/histiocyte-rich large B-cell lymphoma
Whole body metabolic tumor volume is a prognostic marker in patients with newly diagnosed stage 3B non-small cell lung cancer, confirmed with external validation
Missing publications? Search for publications with a matching author name.